- -

Methods to control the pharmaceutical cost impact of chronic conditions in the elderly

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

Methods to control the pharmaceutical cost impact of chronic conditions in the elderly

Mostrar el registro sencillo del ítem

Ficheros en el ítem

[Cerrado]
Nombre: -Vivas-Consuelo;R ...
Tamaño: 457.1Kb
Formato: PDF
Descripción: Versión editorial
Solicitar una copia al autor
dc.contributor.author Vivas Consuelo, David José Juan es_ES
dc.contributor.author Usó Talamantes, Ruth es_ES
dc.contributor.author Trillo Mata, José Luis es_ES
dc.contributor.author Mendez Valera, Pablo es_ES
dc.date.accessioned 2016-05-20T13:06:14Z
dc.date.available 2016-05-20T13:06:14Z
dc.date.issued 2015-06
dc.identifier.issn 1473-7167
dc.identifier.uri http://hdl.handle.net/10251/64486
dc.description.abstract Multimorbidity is the main cause of polypharmacy in elderly people, with the consequent increment in cost and use of inappropriate medication. To control cost, specific strategies have been implemented in healthcare services to reduce potentially inappropriate prescription. Many interventions are applied online during the prescription process using computerized decision support systems, for example, therapeutic algorithms and alerts. Other interventions can be categorized as offline due to their application before or after the prescription process, the main strategies being financial incentives, medication reviews and organizational change. All these strategies are complementary and multifaceted. There is evidence that some of these interventions are effective, but further research should be directed in this field, including investigation of patient cost and outcomes. es_ES
dc.language Inglés es_ES
dc.publisher Expert Reviews (formerly Future Drugs) es_ES
dc.relation.ispartof Expert Review of Pharmacoeconomics and Outcomes Research es_ES
dc.rights Reserva de todos los derechos es_ES
dc.subject Computerized support systems es_ES
dc.subject Cost control es_ES
dc.subject Inappropriate prescribing es_ES
dc.subject Medication-related problems es_ES
dc.subject Multimorbidity es_ES
dc.subject Older people es_ES
dc.subject Polypharmacy es_ES
dc.subject Risk adjustment es_ES
dc.subject.classification ECONOMIA APLICADA es_ES
dc.title Methods to control the pharmaceutical cost impact of chronic conditions in the elderly es_ES
dc.type Artículo es_ES
dc.identifier.doi 10.1586/14737167.2015.1017564
dc.rights.accessRights Cerrado es_ES
dc.contributor.affiliation Universitat Politècnica de València. Departamento de Economía y Ciencias Sociales - Departament d'Economia i Ciències Socials es_ES
dc.description.bibliographicCitation Vivas Consuelo, DJJ.; Usó Talamantes, R.; Trillo Mata, JL.; Mendez Valera, P. (2015). Methods to control the pharmaceutical cost impact of chronic conditions in the elderly. Expert Review of Pharmacoeconomics and Outcomes Research. 15(3):425-427. doi:10.1586/14737167.2015.1017564 es_ES
dc.description.accrualMethod S es_ES
dc.relation.publisherversion http://dx.doi.org/10.1586/14737167.2015.1017564 es_ES
dc.description.upvformatpinicio 425 es_ES
dc.description.upvformatpfin 427 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion es_ES
dc.description.volume 15 es_ES
dc.description.issue 3 es_ES
dc.relation.senia 281873 es_ES
dc.identifier.eissn 1744-8379
dc.description.references Spinewine, A., Schmader, K. E., Barber, N., Hughes, C., Lapane, K. L., Swine, C., & Hanlon, J. T. (2007). Appropriate prescribing in elderly people: how well can it be measured and optimised? The Lancet, 370(9582), 173-184. doi:10.1016/s0140-6736(07)61091-5 es_ES
dc.description.references Wagner, E. H. (2001). Meeting the needs of chronically ill people. BMJ, 323(7319), 945-946. doi:10.1136/bmj.323.7319.945 es_ES
dc.description.references Hoffman, C. (1996). Persons with chronic conditions. Their prevalence and costs. JAMA: The Journal of the American Medical Association, 276(18), 1473-1479. doi:10.1001/jama.276.18.1473 es_ES
dc.description.references Lehnert, T., Heider, D., Leicht, H., Heinrich, S., Corrieri, S., Luppa, M., … König, H.-H. (2011). Review: Health Care Utilization and Costs of Elderly Persons With Multiple Chronic Conditions. Medical Care Research and Review, 68(4), 387-420. doi:10.1177/1077558711399580 es_ES
dc.description.references Mueller, C., Schur, C., & O’Connell, J. (1997). Prescription drug spending: the impact of age and chronic disease status. American Journal of Public Health, 87(10), 1626-1629. doi:10.2105/ajph.87.10.1626 es_ES
dc.description.references Sambamoorthi, U., Shea, D., & Crystal, S. (2003). Total and Out-of-Pocket Expenditures for Prescription Drugs Among Older Persons. The Gerontologist, 43(3), 345-359. doi:10.1093/geront/43.3.345 es_ES
dc.description.references Rogowski, J., Lillard, L. A., & Kington, R. (1997). The Financial Burden of Prescription Drug Use Among Elderly Persons. The Gerontologist, 37(4), 475-482. doi:10.1093/geront/37.4.475 es_ES
dc.description.references Fahlman, C., Lynn, J., Doberman, D., Gabel, J., & Finch, M. (2006). Prescription Drug Spending for Medicare+Choice Beneficiaries in the Last Year of Life. Journal of Palliative Medicine, 9(4), 884-893. doi:10.1089/jpm.2006.9.884 es_ES
dc.description.references Vivas, D., Guadalajara, N., Barrachina, I., Trillo, J.-L., Usó, R., & de-la-Poza, E. (2011). Explaining primary healthcare pharmacy expenditure using classification of medications for chronic conditions. Health Policy, 103(1), 9-15. doi:10.1016/j.healthpol.2011.08.014 es_ES
dc.description.references Kaufman, D. W., Kelly, J. P., Rosenberg, L., Anderson, T. E., & Mitchell, A. A. (2002). Recent Patterns of Medication Use in the Ambulatory Adult Population of the United States. JAMA, 287(3), 337. doi:10.1001/jama.287.3.337 es_ES
dc.description.references Fortin, M., Stewart, M., Poitras, M.-E., Almirall, J., & Maddocks, H. (2012). A Systematic Review of Prevalence Studies on Multimorbidity: Toward a More Uniform Methodology. The Annals of Family Medicine, 10(2), 142-151. doi:10.1370/afm.1337 es_ES
dc.description.references Rollason, V., & Vogt, N. (2003). Reduction of Polypharmacy in the Elderly. Drugs & Aging, 20(11), 817-832. doi:10.2165/00002512-200320110-00003 es_ES
dc.description.references Bradley, M. C., Fahey, T., Cahir, C., Bennett, K., O’Reilly, D., Parsons, C., & Hughes, C. M. (2012). Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database. European Journal of Clinical Pharmacology, 68(10), 1425-1433. doi:10.1007/s00228-012-1249-y es_ES
dc.description.references Vivas-Consuelo, D., Usó-Talamantes, R., Trillo-Mata, J. L., Caballer-Tarazona, M., Barrachina-Martínez, I., & Buigues-Pastor, L. (2014). Predictability of pharmaceutical spending in primary health services using Clinical Risk Groups. Health Policy, 116(2-3), 188-195. doi:10.1016/j.healthpol.2014.01.012 es_ES
dc.description.references Feinstein, A. R. (1970). The pre-therapeutic classification of co-morbidity in chronic disease. Journal of Chronic Diseases, 23(7), 455-468. doi:10.1016/0021-9681(70)90054-8 es_ES
dc.description.references Van den Akker, M., Buntinx, F., Metsemakers, J. F. M., Roos, S., & Knottnerus, J. A. (1998). Multimorbidity in General Practice: Prevalence, Incidence, and Determinants of Co-Occurring Chronic and Recurrent Diseases. Journal of Clinical Epidemiology, 51(5), 367-375. doi:10.1016/s0895-4356(97)00306-5 es_ES
dc.description.references Bayliss, E. A., Ellis, J. L., & Steiner, J. F. (2005). Health and Quality of Life Outcomes, 3(1), 51. doi:10.1186/1477-7525-3-51 es_ES
dc.description.references Valderas, J. M., Starfield, B., Sibbald, B., Salisbury, C., & Roland, M. (2009). Defining Comorbidity: Implications for Understanding Health and Health Services. The Annals of Family Medicine, 7(4), 357-363. doi:10.1370/afm.983 es_ES
dc.description.references Starfield, B. (2006). Threads and Yarns: Weaving the Tapestry of Comorbidity. The Annals of Family Medicine, 4(2), 101-103. doi:10.1370/afm.524 es_ES
dc.description.references Diederichs, C., Berger, K., & Bartels, D. B. (2010). The Measurement of Multiple Chronic Diseases--A Systematic Review on Existing Multimorbidity Indices. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 66A(3), 301-311. doi:10.1093/gerona/glq208 es_ES
dc.description.references Smith, S. M., Soubhi, H., Fortin, M., Hudon, C., & O’Dowd, T. (2012). Managing patients with multimorbidity: systematic review of interventions in primary care and community settings. BMJ, 345(sep03 1), e5205-e5205. doi:10.1136/bmj.e5205 es_ES
dc.description.references Prados-Torres, A., Calderón-Larrañaga, A., Hancco-Saavedra, J., Poblador-Plou, B., & van den Akker, M. (2014). Multimorbidity patterns: a systematic review. Journal of Clinical Epidemiology, 67(3), 254-266. doi:10.1016/j.jclinepi.2013.09.021 es_ES
dc.description.references Bower, P., Harkness, E., Macdonald, W., Coventry, P., Bundy, C., & Moss-Morris, R. (2012). Illness representations in patients with multimorbid long-term conditions: Qualitative study. Psychology & Health, 27(10), 1211-1226. doi:10.1080/08870446.2012.662973 es_ES
dc.description.references Sundararajan, V., Henderson, T., Perry, C., Muggivan, A., Quan, H., & Ghali, W. A. (2004). New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. Journal of Clinical Epidemiology, 57(12), 1288-1294. doi:10.1016/j.jclinepi.2004.03.012 es_ES
dc.description.references Glynn, L. G., Valderas, J. M., Healy, P., Burke, E., Newell, J., Gillespie, P., & Murphy, A. W. (2011). The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Family Practice, 28(5), 516-523. doi:10.1093/fampra/cmr013 es_ES
dc.description.references Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012). Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet, 380(9836), 37-43. doi:10.1016/s0140-6736(12)60240-2 es_ES
dc.description.references Holden, L., Scuffham, P. A., Hilton, M. F., Muspratt, A., Ng, S.-K., & Whiteford, H. A. (2011). Patterns of multimorbidity in working Australians. Population Health Metrics, 9(1). doi:10.1186/1478-7954-9-15 es_ES
dc.description.references Fortin, M., Lapointe, L., Hudon, C., Vanasse, A., Ntetu, A. L., & Maltais, D. (2004). Health and Quality of Life Outcomes, 2(1), 51. doi:10.1186/1477-7525-2-51 es_ES
dc.description.references Schellevis, F. G., van der Velden, J., van de Lisdonk, E., van Eijk, J. T. M., & van Weel, C. (1993). Comorbidity of chronic diseases in general practice. Journal of Clinical Epidemiology, 46(5), 469-473. doi:10.1016/0895-4356(93)90024-u es_ES
dc.description.references Schäfer, I., Hansen, H., Schön, G., Maier, W., Höfels, S., Altiner, A., … van den Bussche, H. (2009). The German MultiCare-study: Patterns of multimorbidity in primary health care – protocol of a prospective cohort study. BMC Health Services Research, 9(1). doi:10.1186/1472-6963-9-145 es_ES
dc.description.references Schäfer, I., von Leitner, E.-C., Schön, G., Koller, D., Hansen, H., Kolonko, T., … van den Bussche, H. (2010). Multimorbidity Patterns in the Elderly: A New Approach of Disease Clustering Identifies Complex Interrelations between Chronic Conditions. PLoS ONE, 5(12), e15941. doi:10.1371/journal.pone.0015941 es_ES
dc.description.references Van den Bussche, H., Koller, D., Kolonko, T., Hansen, H., Wegscheider, K., Glaeske, G., … Schön, G. (2011). Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany. BMC Public Health, 11(1). doi:10.1186/1471-2458-11-101 es_ES
dc.description.references König, H.-H., Leicht, H., Bickel, H., Fuchs, A., Gensichen, J., … Eckardt, M. (2013). Effects of multiple chronic conditions on health care costs: an analysis based on an advanced tree-based regression model. BMC Health Services Research, 13(1). doi:10.1186/1472-6963-13-219 es_ES
dc.description.references Teljeur, C., Smith, S. M., Paul, G., Kelly, A., & O’Dowd, T. (2013). Multimorbidity in a cohort of patients with type 2 diabetes. European Journal of General Practice, 19(1), 17-22. doi:10.3109/13814788.2012.714768 es_ES
dc.description.references Poblador-Plou, B., van den Akker, M., Vos, R., Calderón-Larrañaga, A., Metsemakers, J., & Prados-Torres, A. (2014). Similar Multimorbidity Patterns in Primary Care Patients from Two European Regions: Results of a Factor Analysis. PLoS ONE, 9(6), e100375. doi:10.1371/journal.pone.0100375 es_ES
dc.description.references Fulton, M. M., & Riley Allen, E. (2005). Polypharmacy in the elderly: A literature review. Journal of the American Academy of Nurse Practitioners, 17(4), 123-132. doi:10.1111/j.1041-2972.2005.0020.x es_ES
dc.description.references Boudreau, D. M., Yu, O., Gray, S. L., Raebel, M. A., Johnson, J., & Larson, E. B. (2011). Concomitant Use of Cholinesterase Inhibitors and Anticholinergics: Prevalence and Outcomes. Journal of the American Geriatrics Society, 59(11), 2069-2076. doi:10.1111/j.1532-5415.2011.03654.x es_ES
dc.description.references Veehof, L., Stewart, R., Haaijer-Ruskamp, F., & Jong, B. M. -d. (2000). The development of polypharmacy. A longitudinal study. Family Practice, 17(3), 261-267. doi:10.1093/fampra/17.3.261 es_ES
dc.description.references Fialová, D. (2005). Potentially Inappropriate Medication Use Among Elderly Home Care Patients in Europe. JAMA, 293(11), 1348. doi:10.1001/jama.293.11.1348 es_ES
dc.description.references Bjerrum, L., Rosholm, J. U., Hallas, J., & Kragstrup, J. (1997). Methods for estimating the occurrence of polypharmacy by means of a prescription database. European Journal of Clinical Pharmacology, 53(1), 7-11. doi:10.1007/s002280050329 es_ES
dc.description.references Moen, J., Antonov, K., Larsson, C. A., Lindblad, U., Nilsson, J. L. G., Råstam, L., & Ring, L. (2009). Factors Associated with Multiple Medication Use in Different Age Groups. Annals of Pharmacotherapy, 43(12), 1978-1985. doi:10.1345/aph.1m354 es_ES
dc.description.references Orueta Sánchez, R., Santos Rodríguez, C., González Hidalgo, E., Fagundo Becerra, E. M., Alejandre Lázaro, G., Carmona de la Morena, J., … Butrón Gómez, T. (2011). Medicalización de la vida (I). Revista Clínica de Medicina de Familia, 4(2). doi:10.4321/s1699-695x2011000200011 es_ES
dc.description.references Onder, G., Petrovic, M., Tangiisuran, B., Meinardi, M. C., Markito-Notenboom, W. P., Somers, A., … van der Cammen, T. J. M. (2010). Development and Validation of a Score to Assess Risk of Adverse Drug Reactions Among In-Hospital Patients 65 Years or Older. Archives of Internal Medicine, 170(13). doi:10.1001/archinternmed.2010.153 es_ES
dc.description.references Onder, G., Liperoti, R., Fialova, D., Topinkova, E., Tosato, M., … Danese, P. (2012). Polypharmacy in Nursing Home in Europe: Results From the SHELTER Study. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 67A(6), 698-704. doi:10.1093/gerona/glr233 es_ES
dc.description.references Hanlon, J. T., Schmader, K. E., Koronkowski, M. J., Weinberger, M., Landsman, P. B., Samsa, G. P., & Lewis, I. K. (1997). Adverse Drug Events In High Risk Older Outpatients. Journal of the American Geriatrics Society, 45(8), 945-948. doi:10.1111/j.1532-5415.1997.tb02964.x es_ES
dc.description.references Suelves, J. M., Martínez, V., & Medina, A. (2010). Lesiones por caídas y factores asociados en personas mayores de Cataluña, España. Revista Panamericana de Salud Pública, 27(1), 37-42. doi:10.1590/s1020-49892010000100006 es_ES
dc.description.references Klarin, I., Wimo, A., & Fastbom, J. (2005). The Association of Inappropriate Drug Use with Hospitalisation and Mortality. Drugs & Aging, 22(1), 69-82. doi:10.2165/00002512-200522010-00005 es_ES
dc.description.references Incalzi, A. R., Capparella, O., Gemma, A., Porcedda, P., Raccis, G., Sommella, L., & Carbonin, P. U. (1992). A Simple Method of Recognizing Geriatric Patients at Risk for Death and Disability. Journal of the American Geriatrics Society, 40(1), 34-38. doi:10.1111/j.1532-5415.1992.tb01826.x es_ES
dc.description.references Campbell, S. E., Seymour, D. G., & Primrose, W. R. (2004). A systematic literature review of factors affecting outcome in older medical patients admitted to hospital. Age and Ageing, 33(2), 110-115. doi:10.1093/ageing/afh036 es_ES
dc.description.references Sotoca Momblona, J. M., Canivell Fusté, S., Alemany Vilches, L., Sisó Almirall, A., Codina Jané, C., & Ribas Sala, J. (2009). Problemas relacionados con la medicación que causan ingresos hospitalarios. Atención Primaria, 41(3), 141-146. doi:10.1016/j.aprim.2008.07.002 es_ES
dc.description.references Martín Martínez, M. A., Alférez, R. C., Escortell Mayor, E., Rico Blázquez, M., & Sarría Santamera, A. (2011). Factores asociados a reingresos hospitalarios en pacientes de edad avanzada. Atención Primaria, 43(3), 117-124. doi:10.1016/j.aprim.2009.12.007 es_ES
dc.description.references Kaur, S., Mitchell, G., Vitetta, L., & Roberts, M. S. (2009). Interventions that can Reduce Inappropriate Prescribing in the Elderly. Drugs & Aging, 26(12), 1013-1028. doi:10.2165/11318890-000000000-00000 es_ES
dc.description.references Shojania, K. G., & Grimshaw, J. M. (2005). Evidence-Based Quality Improvement: The State Of The Science. Health Affairs, 24(1), 138-150. doi:10.1377/hlthaff.24.1.138 es_ES
dc.description.references Mossey, J. M., & Roos, L. L. (1987). Using insurance claims to measure health status: The illness scale. Journal of Chronic Diseases, 40, 41S-50S. doi:10.1016/s0021-9681(87)80031-0 es_ES
dc.description.references Von Korff, M., Wagner, E. H., & Saunders, K. (1992). A chronic disease score from automated pharmacy data. Journal of Clinical Epidemiology, 45(2), 197-203. doi:10.1016/0895-4356(92)90016-g es_ES
dc.description.references Malone, D. C., Billups, S. J., Valuck, R. J., & Carter, B. L. (1999). Development of a Chronic Disease Indicator Score Using a Veterans Affairs Medical Center Medication Database. Journal of Clinical Epidemiology, 52(6), 551-557. doi:10.1016/s0895-4356(99)00029-3 es_ES
dc.description.references Clark, D. O., Korff, M. V., Saunders, K., Balugh, W. M., & Simon, G. E. (1995). A Chronic Disease Score with Empirically Derived Weights. Medical Care, 33(8), 783-795. doi:10.1097/00005650-199508000-00004 es_ES
dc.description.references Lamers, L. M. (1999). Pharmacy Costs Groups. Medical Care, 37(8), 824-830. doi:10.1097/00005650-199908000-00012 es_ES
dc.description.references Lamers, L. M. (2001). Health-Based Risk Adjustment: Is Inpatient and Outpatient Diagnostic Information Sufficient? Inquiry, 38(4), 423-431. doi:10.5034/inquiryjrnl_38.4.423 es_ES
dc.description.references Lamers, L. M., & van Vliet, R. C. J. A. (2004). The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation. Health Policy, 68(1), 113-121. doi:10.1016/j.healthpol.2003.09.001 es_ES
dc.description.references Lamers, L. M., & Vliet, R. C. J. A. (2003). Health-based risk adjustment Improving the pharmacy-based cost group. The European Journal of Health Economics, 4(2), 107-114. doi:10.1007/s10198-002-0159-9 es_ES
dc.description.references Johnson, R. E., Hornbrook, M. C., & Nichols, G. A. (1994). Replicating the chronic disease score (CDS) from automated pharmacy data. Journal of Clinical Epidemiology, 47(10), 1191-1199. doi:10.1016/0895-4356(94)90106-6 es_ES
dc.description.references Stam, P. J. A., van Vliet, R. C. J. A., & van de Ven, W. P. M. M. (2010). Diagnostic, Pharmacy-Based, and Self-Reported Health Measures in Risk Equalization Models. Medical Care, 48(5), 448-457. doi:10.1097/mlr.0b013e3181d559b4 es_ES
dc.description.references Weiner, J. P., Starfield, B. H., Steinwachs, D. M., & Mumford, L. M. (1991). Development and Application of a Population-Oriented Measure of Ambulatory Care Case-Mix. Medical Care, 29(5), 452-472. doi:10.1097/00005650-199105000-00006 es_ES
dc.description.references Hughes, J. S., Averill, R. F., Eisenhandler, J., Goldfield, N. I., Muldoon, J., Neff, J. M., & Gay, J. C. (2004). Clinical Risk Groups (CRGs). Medical Care, 42(1), 81-90. doi:10.1097/01.mlr.0000102367.93252.70 es_ES
dc.description.references García-Goñi, M., & Ibern, P. (2007). Predictability of drug expenditures: an application using morbidity data. Health Economics, 17(1), 119-126. doi:10.1002/hec.1238 es_ES
dc.description.references García-Goñi, M., Ibern, P., & Inoriza, J. M. (2008). Hybrid risk adjustment for pharmaceutical benefits. The European Journal of Health Economics, 10(3), 299-308. doi:10.1007/s10198-008-0133-2 es_ES
dc.description.references Hanley, G. E., Morgan, S., & Reid, R. J. (2010). Explaining Prescription Drug Use and Expenditures Using the Adjusted Clinical Groups Case-Mix System in the Population of British Columbia, Canada. Medical Care, 48(5), 402-408. doi:10.1097/mlr.0b013e3181ca3d5d es_ES
dc.description.references Buchner, F., Goepffarth, D., & Wasem, J. (2013). The new risk adjustment formula in Germany: Implementation and first experiences. Health Policy, 109(3), 253-262. doi:10.1016/j.healthpol.2012.12.001 es_ES
dc.description.references Vivas-Consuelo, D., Usó-Talamantes, R., Guadalajara-Olmeda, N., Trillo-Mata, J.-L., Sancho-Mestre, C., & Buigues-Pastor, L. (2014). Pharmaceutical cost management in an ambulatory setting using a risk adjustment tool. BMC Health Services Research, 14(1). doi:10.1186/1472-6963-14-462 es_ES
dc.description.references Lane, C. J., Bronskill, S. E., Sykora, K., Dhalla, I. A., Anderson, G. M., Mamdani, M. M., … Rochon, P. A. (2004). Potentially Inappropriate Prescribing in Ontario Community-Dwelling Older Adults and Nursing Home Residents. Journal of the American Geriatrics Society, 52(6), 861-866. doi:10.1111/j.1532-5415.2004.52250.x es_ES
dc.description.references King, M. A., & Roberts, M. S. (2007). The influence of the Pharmaceutical Benefits Scheme (PBS) on inappropriate prescribing in Australian nursing homes. Pharmacy World & Science, 29(1), 39-42. doi:10.1007/s11096-005-5618-9 es_ES
dc.description.references Bradley, M. C., Motterlini, N., Padmanabhan, S., Cahir, C., Williams, T., Fahey, T., & Hughes, C. M. (2014). Potentially inappropriate prescribing among older people in the United Kingdom. BMC Geriatrics, 14(1). doi:10.1186/1471-2318-14-72 es_ES
dc.description.references Dalleur, O., Boland, B., Losseau, C., Henrard, S., Wouters, D., Speybroeck, N., … Spinewine, A. (2014). Reduction of Potentially Inappropriate Medications Using the STOPP Criteria in Frail Older Inpatients: A Randomised Controlled Study. Drugs & Aging, 31(4), 291-298. doi:10.1007/s40266-014-0157-5 es_ES
dc.description.references Wessell, A. M., Nietert, P. J., Jenkins, R. G., Nemeth, L. S., & Ornstein, S. M. (2008). Inappropriate medication use in the elderly: Results from a quality improvement project in 99 primary care practices. The American Journal of Geriatric Pharmacotherapy, 6(1), 21-27. doi:10.1016/j.amjopharm.2008.02.001 es_ES
dc.description.references Beers, M. H. (1991). Explicit Criteria for Determining Inappropriate Medication Use in Nursing Home Residents. Archives of Internal Medicine, 151(9), 1825. doi:10.1001/archinte.1991.00400090107019 es_ES
dc.description.references Knight, E. L. (2001). Quality Indicators for Appropriate Medication Use in Vulnerable Elders. Annals of Internal Medicine, 135(8_Part_2), 703. doi:10.7326/0003-4819-135-8_part_2-200110161-00009 es_ES
dc.description.references Fick, D. M., Cooper, J. W., Wade, W. E., Waller, J. L., Maclean, J. R., & Beers, M. H. (2003). Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. Archives of Internal Medicine, 163(22), 2716. doi:10.1001/archinte.163.22.2716 es_ES
dc.description.references Gallagher, P., Ryan, C., Byrne, S., Kennedy, J., & O Mahony, D. (2008). STOPP (Screening Tool of Older Person s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int. Journal of Clinical Pharmacology and Therapeutics, 46(02), 72-83. doi:10.5414/cpp46072 es_ES
dc.description.references Delgado Silveira, E., Muñoz García, M., Montero Errasquin, B., Sánchez Castellano, C., Gallagher, P. F., & Cruz-Jentoft, A. J. (2009). Prescripción inapropiada de medicamentos en los pacientes mayores: los criterios STOPP/START. Revista Española de Geriatría y Gerontología, 44(5), 273-279. doi:10.1016/j.regg.2009.03.017 es_ES
dc.description.references Barry, P. J., Gallagher, P., Ryan, C., & O’mahony, D. (2007). START (screening tool to alert doctors to the right treatment) an evidence-based screening tool to detect prescribing omissions in elderly patients. Age and Ageing, 36(6), 632-638. doi:10.1093/ageing/afm118 es_ES
dc.description.references Wenger, N. S. (2001). Assessing Care of Vulnerable Elders: ACOVE Project Overview. Annals of Internal Medicine, 135(8_Part_2), 642. doi:10.7326/0003-4819-135-8_part_2-200110161-00002 es_ES
dc.description.references Fick, D. M., Mion, L. C., Beers, M. H., & L. Waller, J. (2008). Health outcomes associated with potentially inappropriate medication use in older adults. Research in Nursing & Health, 31(1), 42-51. doi:10.1002/nur.20232 es_ES
dc.description.references Clyne, B., Bradley, M. C., Hughes, C., Fahey, T., & Lapane, K. L. (2012). Electronic Prescribing and Other Forms of Technology to Reduce Inappropriate Medication Use and Polypharmacy in Older People: A Review of Current Evidence. Clinics in Geriatric Medicine, 28(2), 301-322. doi:10.1016/j.cger.2012.01.009 es_ES
dc.description.references Curtain, C., & Peterson, G. M. (2014). Review of computerized clinical decision support in community pharmacy. Journal of Clinical Pharmacy and Therapeutics, 39(4), 343-348. doi:10.1111/jcpt.12168 es_ES
dc.description.references Raebel, M. A., Charles, J., Dugan, J., Carroll, N. M., Korner, E. J., Brand, D. W., & Magid, D. J. (2007). Randomized Trial to Improve Prescribing Safety in Ambulatory Elderly Patients. Journal of the American Geriatrics Society, 55(7), 977-985. doi:10.1111/j.1532-5415.2007.01202.x es_ES
dc.description.references Crotty, M., Rowett, D., Spurling, L., Giles, L. C., & Phillips, P. A. (2004). Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. The American Journal of Geriatric Pharmacotherapy, 2(4), 257-264. doi:10.1016/j.amjopharm.2005.01.001 es_ES
dc.description.references Clyne, B., Bradley, M. C., Smith, S. M., Hughes, C. M., Motterlini, N., … Clear, D. (2013). Effectiveness of medicines review with web-based pharmaceutical treatment algorithms in reducing potentially inappropriate prescribing in older people in primary care: a cluster randomized trial (OPTI-SCRIPT study protocol). Trials, 14(1), 72. doi:10.1186/1745-6215-14-72 es_ES
dc.description.references Hanlon, J. T., Weinberger, M., Samsa, G. P., Schmader, K. E., Uttech, K. M., Lewis, I. K., … Feussner, J. R. (1996). A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. The American Journal of Medicine, 100(4), 428-437. doi:10.1016/s0002-9343(97)89519-8 es_ES
dc.description.references Krska, J. (2001). Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age and Ageing, 30(3), 205-211. doi:10.1093/ageing/30.3.205 es_ES
dc.description.references Saltvedt, I., Spigset, O., Ruths, S., Fayers, P., Kaasa, S., & Sletvold, O. (2005). Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomised study. European Journal of Clinical Pharmacology, 61(12), 921-928. doi:10.1007/s00228-005-0046-2 es_ES
dc.description.references Meredith, S., Feldman, P., Frey, D., Giammarco, L., Hall, K., Arnold, K., … Ray, W. A. (2002). Improving Medication Use in Newly Admitted Home Healthcare Patients: A Randomized Controlled Trial. Journal of the American Geriatrics Society, 50(9), 1484-1491. doi:10.1046/j.1532-5415.2002.50402.x es_ES
dc.description.references Kim, J., Ahn, B.-J., Chae, H.-S., Han, S., Doh, K., Choi, J., … Yim, D.-S. (2011). A Population Pharmacokinetic-Pharmacodynamic Model for Simvastatin that Predicts Low-Density Lipoprotein-Cholesterol Reduction in Patients with Primary Hyperlipidaemia. Basic & Clinical Pharmacology & Toxicology, 109(3), 156-163. doi:10.1111/j.1742-7843.2011.00700.x es_ES
dc.description.references Reeve, E., Shakib, S., Hendrix, I., Roberts, M. S., & Wiese, M. D. (2014). Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. British Journal of Clinical Pharmacology, 78(4), 738-747. doi:10.1111/bcp.12386 es_ES
dc.description.references Zermansky, A. G., Alldred, D. P., Petty, D. R., Raynor, D. K., Freemantle, N., Eastaugh, J., & Bowie, P. (2006). Clinical medication review by a pharmacist of elderly people living in care homes—randomised controlled trial. Age and Ageing, 35(6), 586-591. doi:10.1093/ageing/afl075 es_ES
dc.description.references Salisbury, C. (2013). Multimorbidity: time for action rather than words. British Journal of General Practice, 63(607), 64-65. doi:10.3399/bjgp13x661020 es_ES
dc.description.references Roland, M., & Paddison, C. (2013). Better management of patients with multimorbidity. BMJ, 346(may02 1), f2510-f2510. doi:10.1136/bmj.f2510 es_ES
dc.description.references Ammenwerth, E., Duftschmid, G., Gall, W., Hackl, W. O., Hoerbst, A., Janzek-Hawlat, S., … Dorda, W. (2014). A nationwide computerized patient medication history: Evaluation of the Austrian pilot project «e-Medikation». International Journal of Medical Informatics, 83(9), 655-669. doi:10.1016/j.ijmedinf.2014.06.004 es_ES


Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem